CVS Health Co. (NYSE:CVS) Stake Increased by Bontempo Ohly Capital Mgmt LLC

Bontempo Ohly Capital Mgmt LLC increased its holdings in CVS Health Co. (NYSE:CVS) by 1.8% in the 4th quarter, Holdings Channel reports. The fund owned 52,595 shares of the pharmacy operator’s stock after purchasing an additional 932 shares during the period. CVS Health makes up about 1.1% of Bontempo Ohly Capital Mgmt LLC’s portfolio, making the stock its 23rd biggest position. Bontempo Ohly Capital Mgmt LLC’s holdings in CVS Health were worth $2,361,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Coppell Advisory Solutions LLC increased its stake in CVS Health by 17.3% in the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator’s stock valued at $56,000 after buying an additional 189 shares during the period. EagleClaw Capital Managment LLC grew its holdings in shares of CVS Health by 3.4% during the 4th quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator’s stock valued at $275,000 after acquiring an additional 200 shares in the last quarter. Manchester Capital Management LLC increased its stake in shares of CVS Health by 4.8% in the fourth quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator’s stock worth $200,000 after acquiring an additional 204 shares during the last quarter. Angeles Investment Advisors LLC raised its holdings in shares of CVS Health by 3.7% during the fourth quarter. Angeles Investment Advisors LLC now owns 5,706 shares of the pharmacy operator’s stock worth $256,000 after acquiring an additional 204 shares in the last quarter. Finally, Rogco LP boosted its position in CVS Health by 3.2% during the fourth quarter. Rogco LP now owns 6,752 shares of the pharmacy operator’s stock valued at $303,000 after purchasing an additional 210 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, SVP James David Clark sold 7,513 shares of the stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares of the company’s stock, valued at approximately $556,941.90. This represents a 47.23 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Michael F. Mahoney purchased 30,000 shares of the stock in a transaction on Tuesday, February 18th. The stock was bought at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now directly owns 39,356 shares of the company’s stock, valued at approximately $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.22% of the company’s stock.

CVS Health Stock Performance

NYSE:CVS opened at $67.09 on Tuesday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The firm’s 50-day moving average is $66.79 and its 200-day moving average is $58.81. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $72.51. The company has a market cap of $84.59 billion, a price-to-earnings ratio of 18.33, a PEG ratio of 0.98 and a beta of 0.60.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The firm had revenue of $94.59 billion during the quarter, compared to analysts’ expectations of $93.07 billion. During the same quarter in the prior year, the firm posted $1.31 EPS. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. Equities research analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.96%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health’s dividend payout ratio (DPR) is presently 63.48%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Piper Sandler boosted their price target on CVS Health from $72.00 to $74.00 and gave the company an “overweight” rating in a research note on Friday, March 21st. Royal Bank of Canada boosted their target price on shares of CVS Health from $74.00 to $81.00 and gave the stock an “outperform” rating in a research report on Monday. Argus set a $77.00 price target on shares of CVS Health in a report on Tuesday, February 18th. Morgan Stanley reiterated an “overweight” rating on shares of CVS Health in a report on Tuesday, April 15th. Finally, StockNews.com upgraded CVS Health from a “sell” rating to a “hold” rating in a report on Thursday, February 13th. Four investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $74.13.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.